Particle.news

Download on the App Store

House Subcommittee Advances Bill to Ban Hemp-Derived THC Products

It includes exemptions for FDA-approved medications such as Epidiolex in a bid to close the hemp loophole

Various wellness products containing full spectrum Cannabidiol (CBD) from R+R Medicinals, including oil tinctures, topical cream, edible gummies, and pet products visible on the shelves of a boutique retail store in Denver, Colorado, August 9, 2020.
Image
Image

Overview

  • The House Appropriations Subcommittee advanced an amendment to redefine federally legal hemp to exclude products containing quantifiable THC or similar cannabinoids.
  • If the full committee approves the change on June 11, most hemp-derived cannabinoid products, including Delta-8 edibles and smokable hemp flower, would be illegal nationwide.
  • Industry groups such as the U.S. Hemp Roundtable warn that the measure could devastate the legal hemp market, while Smart Approaches to Marijuana calls it a vital step to curb unregulated intoxicants.
  • The proposal includes exemptions for FDA-approved medications such as Epidiolex but has raised concerns that prohibition could push consumers toward unregulated products and illicit suppliers.
  • Several states, including Texas and Nebraska, have moved to restrict or ban THC products, creating a patchwork of regulations across the U.S.